NFE2L2 and rheumatoid arthritis: We demonstrated that PE-EVOO treatment increased the levels of phosphorylated and active forms of Nrf2 in RA patients and HS LPS-stimulated PBMCs, while the levels of total Nrf2 did not change (Figure 7).